Ronald J. van der Sluis et al. induced long‐term receptor antagonist Del1‐9‐G129R‐hPRL in mice by bone marrow transplantation in irradiated atherosclerosis‐susceptible LDL receptor knockout mice and found blocking PRLR reduced the atherogenic index but had no effect on the initial development of atherosclerotic lesions.59 Here, PRLR is linked to atherosclerosis.